Table III.

Levels of tested biomarkers in patients with intrahepatic cholestasis of pregnancy with a history of intrahepatic cholestasis of pregnancy and without a history of intrahepatic cholestasis of pregnancy and the control group

Variable	β-klotho [pg/ml]	FGF-19 [pg/ml]
ICP without H/O ICP (n = 14)	468.84 (463.24)	54.58 (21.94)
ICP with H/O ICP (n = 8)	221.27 (211.68)	41.84 (25.19)
Controls (n = 23)	520.56 (802.70)	48.20 (38.75)
P-values	0.017	0.461

ICP – intrahepatic cholestasis of pregnancy, H/O ICP – previous history of intrahepatic cholestasis of pregnancy among the multipara. Values are given as the median (interquartile range). Group medians were compared using the Kruskal-Wallis test, followed by the Conover post hoc analysis for the two-group pairwise comparisons.